The comparative effects of recombinant human erythropoietin and darbepoetin-alpha on cerebral vasospasm following experimental subarachnoid hemorrhage in the rabbit

[21] Rodriguez M(2003)Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin Exp Hematol 31 290-5631

[22] Nag M(2002)Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage Proc Natl Acad Sci U S A 99 5627-570

[23] Adamson JW(2002)Does administration of recombinant human erythropoietin attenuate the increase of S-100 protein observed in cerebrospinal fluid after experimental subarachnoid hemorrhage? J Neurosurg 96 565-700

[24] Banks WA(2010)Erythropoietin and subarachnoid hemorrhage J Neurosurg 112 699-63

[25] Jumbe NL(2004)An overview of new pharmacological treatments for cerebrovascular dysfunction after experimental subarachnoid hemorrhage Brain Res Brain Res Rev 44 49-14

[26] Farrell CL(2001)Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage J Neurosurg Sci 45 7-567

[27] Niehoff ML(2012)High dose erythropoietin increases brain tissue oxygen tension in severe vasospasm after subarachnoid hemorrhage BMC Neurol 12 32-489

[28] Heatherington AC(1996)Changes in endothelial nitric oxide synthase mRNA during vasospasm after subarachnoid hemorrhage in monkeys Neurosurgery 39 562-572

[29] Belen D(1992)Erythropoietin: structure, control of production, and function Physiol Rev 72 449-1436

[30] Besalti O(1985)Cerebral vasospasm following aneurysmal subarachnoid hemorrhage Stroke 16 562-678

[21] Rodriguez M(2003)Darbepoetin alfa has a longer circulating half-life and greater in vivo potency than recombinant human erythropoietin Exp Hematol 31 290-5631

[22] Nag M(2002)Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage Proc Natl Acad Sci U S A 99 5627-570

[23] Adamson JW(2002)Does administration of recombinant human erythropoietin attenuate the increase of S-100 protein observed in cerebrospinal fluid after experimental subarachnoid hemorrhage? J Neurosurg 96 565-700

[24] Banks WA(2010)Erythropoietin and subarachnoid hemorrhage J Neurosurg 112 699-63

[25] Jumbe NL(2004)An overview of new pharmacological treatments for cerebrovascular dysfunction after experimental subarachnoid hemorrhage Brain Res Brain Res Rev 44 49-14

[26] Farrell CL(2001)Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage J Neurosurg Sci 45 7-567

[27] Niehoff ML(2012)High dose erythropoietin increases brain tissue oxygen tension in severe vasospasm after subarachnoid hemorrhage BMC Neurol 12 32-489

[28] Heatherington AC(1996)Changes in endothelial nitric oxide synthase mRNA during vasospasm after subarachnoid hemorrhage in monkeys Neurosurgery 39 562-572

[29] Belen D(1992)Erythropoietin: structure, control of production, and function Physiol Rev 72 449-1436

[30] Besalti O(1985)Cerebral vasospasm following aneurysmal subarachnoid hemorrhage Stroke 16 562-678